CytoSeek Revenue and Competitors
Estimated Revenue & Valuation
- CytoSeek's estimated annual revenue is currently $612k per year.
- CytoSeek's estimated revenue per employee is $61,200
Employee Data
- CytoSeek has 10 Employees.
- CytoSeek grew their employee count by -44% last year.
CytoSeek's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Technical Operations | Reveal Email/Phone |
3 | Director, CSO | Reveal Email/Phone |
4 | Senior Protein Scientist | Reveal Email/Phone |
5 | Principal scientist - T-cell engineering | Reveal Email/Phone |
6 | In Vivo and Technical Support Scientist | Reveal Email/Phone |
CytoSeek Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13M | 127 | 43% | N/A | N/A |
#2 | $11.2M | 110 | 62% | N/A | N/A |
#3 | $27.3M | 243 | 10% | N/A | N/A |
#4 | $26M | 237 | 25% | $11M | N/A |
#5 | $3.3M | 41 | -11% | N/A | N/A |
#6 | $11.6M | 114 | 24% | N/A | N/A |
#7 | $1.6M | 22 | 5% | N/A | N/A |
#8 | $34.9M | 548 | 18% | N/A | N/A |
#9 | $50.2M | 394 | -5% | N/A | N/A |
#10 | $13.6M | 243 | -10% | N/A | N/A |
What Is CytoSeek?
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.
keywords:N/AN/A
Total Funding
10
Number of Employees
$612k
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CytoSeek News
... Ventures having led investment rounds totalling £7.5 million and directly invested in two of those companies Imophoron and Cytoseek.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | N/A | N/A |
#2 | N/A | 10 | 150% | N/A |
#3 | $0.6M | 11 | -27% | N/A |
#4 | $1.6M | 11 | 0% | N/A |
#5 | $0.4M | 11 | 0% | N/A |